InvestorsHub Logo
Followers 26
Posts 429
Boards Moderated 0
Alias Born 05/31/2015

Re: None

Saturday, 04/28/2018 9:35:17 PM

Saturday, April 28, 2018 9:35:17 PM

Post# of 689198
IMO the time it takes to unblind the trial will not matter. I am not concerned if they want to wait. All I want is numbers from the March refresh this year. The coming publication will give us a little detailed breakdown of patients. How many were treated right after cheo/rad and crossed over, vs how many weee not able to crossover. Comparing those two groups is meaningless because they are so different. What is important to me is how many are alive at the refresh of data this March/April. If it is anywhere above 80 this is rarely seen gamechanger. Patients and care givers will see that. It will be demanded by them I would bet in it. Northwest will have to do nothing IMO, things will be done for them. So many possibilities at that point including buyot oppurunities.

I think there will be a buyout at some point. It is a major reason I think Cognate was able to be sold. Linda probably needed to seperate herself to get the SEC to back off some. But someone still had to buy it. Cognate is a failure without NWBO succeeding. The people who bought it know fully well if NWBO is bought out they need Cognate to make the vaccine. To reproduce what Cognate has would take years, Cognate knows that. They will not only get rich from stock. Would those who bought Cognate do it if they thought Northwest would fail.

All that matters now is data on L that can be interpreted with some certaintly. D should be in the background. I personally can’t wait to see what D can do. I look forward to not have to do so many fruitless surgeries.

I am gonna stop. I could write about 50 more posts but I end up just getting frustrated and don’t have the time to respond. Good luck to those who believe.

A
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News